Cogent Biosciences(COGT)

11.17 -0.06 -0.53%

今开:11.2昨收:11.23
最高:11.21 最低:11.0
涨停价:0.0跌停价:0.0
总市值:7.80709658E8

Cogent Biosciences的热门评论

持股变动声明

Cogent Biosciences(COGT)06-10 05:12

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021636 Size: 9 KB 网页链接查看全文

招股说明书

Cogent Biosciences(COGT)06-16 05:21

$Cogent Biosciences(COGT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-174881 Act: 33 Size: 578 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)06-10 05:12

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021643 Size: 10 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)06-10 05:12

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021639 Size: 10 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)06-10 05:18

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021648 Size: 5 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)06-10 19:18

$Cogent Biosciences(COGT)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-22-171489 Act: 34 Size: 10 MB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)06-10 05:18

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021646 Size: 9 KB 网页链接查看全文

招股说明书

Cogent Biosciences(COGT)06-14 18:06

$Cogent Biosciences(COGT)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-22-173230 Act: 34 Size: 37 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)06-16 05:27

$Cogent Biosciences(COGT)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-22-174885 Act: 34 Size: 512 KB 网页链接查看全文

生效批准

Cogent Biosciences(COGT)05-25 18:12

$Cogent Biosciences(COGT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-001579 Act: 33 Size: 1 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的最新评论

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20